 |
PDBsum entry 2ajc
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
2ajc
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Porcine dipeptidyl peptidase iv (cd26) in complex with 4-(2- aminoethyl)-benzene sulphonyl fluoride (aebsf)
|
|
Structure:
|
 |
Dipeptidyl peptidase 4. Chain: a, b, c, d. Fragment: extracellular domain. Synonym: dipeptidyl peptidase iv, dpp iv, t-cell activation antigen cd26, tp103, adenosine deaminase complexing protein-2, adabp. Ec: 3.4.14.5
|
|
Source:
|
 |
Sus scrofa. Pig. Organism_taxid: 9823. Organ: kidney
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
1.95Å
|
R-factor:
|
0.202
|
R-free:
|
0.234
|
|
|
Authors:
|
 |
M.Engel,T.Hoffmann,S.Manhart,U.Heiser,S.Chambre,R.Huber,H.U.Demuth, W.Bode
|
Key ref:
|
 |
M.Engel
et al.
(2006).
Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV.
J Mol Biol,
355,
768-783.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
01-Aug-05
|
Release date:
|
28-Feb-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P22411
(DPP4_PIG) -
Dipeptidyl peptidase 4 from Sus scrofa
|
|
|
|
Seq: Struc:
|
 |
 |
 |
766 a.a.
728 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.14.5
- dipeptidyl-peptidase Iv.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Release of an N-terminal dipeptide, Xaa-Xbb-|-Xcc, from a polypeptide, preferentially when Xbb is Pro, provided Xcc is neither Pro nor hydroxyproline.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
355:768-783
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV.
|
|
M.Engel,
T.Hoffmann,
S.Manhart,
U.Heiser,
S.Chambre,
R.Huber,
H.U.Demuth,
W.Bode.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Dipeptidyl peptidase IV (DPIV) is an alpha,beta-hydrolase-like serine
exopeptidase, which removes dipeptides, preferentially with a C-terminal l-Pro
residue, from the N terminus of longer peptide substrates. Previously, we
determined the tetrameric 1.8A crystal structure of native porcine DPIV. Each
monomer is composed of a beta-propeller and a catalytic domain, which together
embrace an internal cavity housing the active centre. This cavity is connected
to the bulk solvent by a "propeller opening" and a "side
opening". Here, we analyse DPIV complexes with a t-butyl-Gly-Pro-Ile
tripeptide, Pro-boroPro, a piperazine purine compound, and aminoethyl phenyl
sulfonylfluoride. The latter two compounds bind to the active-site groove in a
compact and a quite bulky manner, respectively, causing considerable shifts of
the catalytic Ser630 side-chain and of the Tyr547 phenolic group, which forms
the oxyanion hole. The tripeptide, mimicking a peptide substrate, is clamped to
the active site through tight interactions via its N-terminal alpha-ammonium
group, the P2 carbonyl group, the P1-l-Pro side-chain, the C-terminal
carboxylate group, and the stable orthoacid ester amide formed between the
scissile peptide carbonyl group and Ser630 O(gamma). This stable trapping of the
tripeptide could be due to stabilization of the protonated His740 imidazolium
cation by the adjacent negatively charged C-terminal carboxylate group,
preventing proton transfer to the leaving group nitrogen atom. Docking
experiments with the compact rigid 58 residue protein aprotinin, which had been
shown to be processed by DPIV, indicate that the Arg1-Pro2 N terminus can access
the DPIV active site only upon widening of its side openings, probably by
separation of the first and the last propeller blades, and/or of the catalytic
and the propeller domain.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. Covalent and non-covalent binding of inhibitors
(green, carbon; red, oxygen; and blue, nitrogen) towards the
DPIV active site (active residues, light blue; enzyme residues,
beige). Intermolecular hydrogen bonds are given as broken black
lines, the 2F[obs] -F[calc] electron density omit maps (blue
mesh, contoured at 1s) are given for the inhibitor alone. The
Figure was prepared using the program PYMOL
(http://pymol.sourceforge.net/). (a) Ball-and-stick
representation of l-Pro-l-boroPro in complex with DPIV. (b)
Ball-and-stick representation of
7-benzyl-1,3-dimethyl-8-piperazin-1-yl-3,7-dihydro-purine-2,6-dione
(BDPX) shown against the solid surface of the DPIV residues
around the active site. (c) Ball-and-stick representation of
BDPX against the DPIV active site.
|
 |
Figure 5.
Figure 5. Covalent binding of the 4-(2-aminoethyl)-benzene
sulphonyl fluoride inhibitor (AEBSF, ball-and-stick
representation: green, carbon; red, oxygen; and blue, nitrogen)
towards the active site of DPIV. The Figures was were prepared
using the program PYMOL (http://pymol.sourceforge.net/). (a)
Surface representation of the DPIV residues around the active
site. (b) Ball-and-stick representation of the DPIV residues (in
light blue) and around the active site (beige). Intermolecular
hydrogen bonds are given as broken black lines, the 2F[obs]
-F[calc] electron density omit map (blue mesh, contoured at 1s)
is given for the inhibitor and the Tyr547 phenolic group of DPIV.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2006,
355,
768-783)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.R.Pitman,
R.I.Menz,
and
C.A.Abbott
(2010).
Hydrophilic residues surrounding the S1 and S2 pockets contribute to dimerisation and catalysis in human dipeptidyl peptidase 8 (DP8).
|
| |
Biol Chem,
391,
959-972.
|
 |
|
|
|
|
 |
I.M.Al-Masri,
M.K.Mohammad,
and
M.O.Taha
(2008).
Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
|
| |
ChemMedChem,
3,
1763-1779.
|
 |
|
|
|
|
 |
A.J.Barrett,
and
N.D.Rawlings
(2007).
'Species' of peptidases.
|
| |
Biol Chem,
388,
1151-1157.
|
 |
|
|
|
|
 |
H.Hiramatsu,
K.Kyono,
A.Yamamoto,
K.Saeki,
H.Shima,
S.Sugiyama,
K.Inaka,
and
R.Shimizu
(2007).
Crystal structures of human dipeptidyl peptidase IV in its apo and diprotin B-complexed forms.
|
| |
Acta Biochim Biophys Sin (Shanghai),
39,
335-343.
|
 |
|
|
|
|
 |
J.Zeng,
G.Liu,
Y.Tang,
and
H.Jiang
(2007).
3D-QSAR studies on fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors by CoMFA and CoMSIA.
|
| |
J Mol Model,
13,
993.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |